Attached files

file filename
EX-32.2 - EX-32.2 - Replimune Group, Inc.a19-26434_3ex32d2.htm
EX-31.2 - EX-31.2 - Replimune Group, Inc.a19-26434_3ex31d2.htm
EX-31.1 - EX-31.1 - Replimune Group, Inc.a19-26434_3ex31d1.htm
EX-10.2 - EX-10.2 - Replimune Group, Inc.a19-26434_3ex10d2.htm
10-Q - 10-Q - Replimune Group, Inc.a19-26434_310q.htm

Exhibit 32.1

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

 

AS ADOPTED PURSUANT TO

 

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q of Replimune Group, Inc. (the “Company”) for the period ended December 31, 2019, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Philip Astley-Sparke, Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:

 

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: February 13, 2020

By:

/s/ Philip Astley-Sparke

 

 

Philip Astley-Sparke

 

 

Chief Executive Officer

 

 

(Principal Executive Officer)